Lexaria Bioscience Corp. held its annual shareholder meeting on January 27, 2026. Shareholders approved the election of Richard Christopher, John Docherty, Christopher Bunka, Nicholas Baxter, William Edward (Ted) McKechnie, Albert Reese Jr., and Bal Bhullar as directors. The appointment of Malone Bailey LLP as auditors was approved. The ratification of the lawful actions of the directors for the past year was also approved.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexaria Bioscience Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001640334-26-000162), on January 28, 2026, and is solely responsible for the information contained therein.